USD 51.03
(-4.1%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | 163.87 Million USD | 30.99% |
2023 | 125.1 Million USD | 10.19% |
2022 | 113.53 Million USD | 113.0% |
2021 | 53.3 Million USD | 140.5% |
2020 | 22.16 Million USD | 220.23% |
2019 | 6.92 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 FY | 171.81 Million USD | 37.33% |
2024 Q4 | 41.85 Million USD | -28.52% |
2024 Q2 | 33.79 Million USD | 13.84% |
2024 Q3 | 58.55 Million USD | 73.27% |
2024 Q1 | 29.68 Million USD | -9.62% |
2023 Q3 | 38.48 Million USD | 19.88% |
2023 FY | 125.1 Million USD | 10.19% |
2023 Q4 | 32.84 Million USD | -14.66% |
2023 Q2 | 32.1 Million USD | 48.05% |
2023 Q1 | 21.68 Million USD | -22.35% |
2022 Q3 | 35.78 Million USD | 43.44% |
2022 Q4 | 27.92 Million USD | -21.98% |
2022 Q1 | 24.87 Million USD | 8.88% |
2022 FY | 113.53 Million USD | 113.0% |
2022 Q2 | 24.95 Million USD | 0.31% |
2021 Q4 | 22.84 Million USD | 27.38% |
2021 FY | 53.3 Million USD | 140.5% |
2021 Q1 | 2.08 Million USD | -81.17% |
2021 Q3 | 17.93 Million USD | 71.85% |
2021 Q2 | 10.43 Million USD | 401.06% |
2020 Q3 | 7.41 Million USD | 0.0% |
2020 Q4 | 11.06 Million USD | 49.12% |
2020 FY | 22.16 Million USD | 220.23% |
2019 FY | 6.92 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Well Corporation | -692.14 Million USD | 123.677% |
Evolent Health, Inc. | -71.21 Million USD | 330.13% |
MultiPlan Corporation | 173.4 Million USD | 5.494% |
Phreesia, Inc. | -131.77 Million USD | 224.364% |
Teladoc Health, Inc. | -248.55 Million USD | 165.933% |
Veeva Systems Inc. | 429.33 Million USD | 61.83% |